PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,493 | +52.4% | 384,854 | +23.4% | 0.00% | – |
| Q2 2023 | $358,707 | +6.0% | 311,919 | -2.3% | 0.00% | – |
| Q1 2023 | $338,482 | -29.0% | 319,323 | +1.8% | 0.00% | – |
| Q4 2022 | $477,012 | -24.3% | 313,824 | +5.5% | 0.00% | – |
| Q3 2022 | $630,000 | +39.1% | 297,503 | -12.0% | 0.00% | – |
| Q2 2022 | $453,000 | -74.7% | 338,036 | -60.2% | 0.00% | – |
| Q1 2022 | $1,792,000 | +17.7% | 849,464 | +107.1% | 0.00% | – |
| Q4 2021 | $1,522,000 | -15.4% | 410,096 | +13.8% | 0.00% | – |
| Q3 2021 | $1,798,000 | +26.3% | 360,285 | +64.9% | 0.00% | – |
| Q2 2021 | $1,424,000 | +2.8% | 218,488 | +8.7% | 0.00% | – |
| Q1 2021 | $1,385,000 | -38.9% | 201,007 | -9.5% | 0.00% | -100.0% |
| Q4 2020 | $2,265,000 | +86.1% | 222,134 | -36.1% | 0.00% | – |
| Q3 2020 | $1,217,000 | -11.7% | 347,720 | +25.9% | 0.00% | – |
| Q2 2020 | $1,378,000 | +22.2% | 276,144 | -16.8% | 0.00% | – |
| Q1 2020 | $1,128,000 | – | 331,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |